This is a preprint.
The Kelch 3 motif on gigaxonin mediates the interaction with NUDCD3 and regulates vimentin filament morphology
- PMID: 40161598
- PMCID: PMC11952450
- DOI: 10.1101/2025.03.10.641328
The Kelch 3 motif on gigaxonin mediates the interaction with NUDCD3 and regulates vimentin filament morphology
Update in
-
The Kelch 3 motif on gigaxonin mediates the interaction with NUDCD3 and regulates vimentin filament morphology.Eur J Cell Biol. 2025 Sep;104(3):151508. doi: 10.1016/j.ejcb.2025.151508. Epub 2025 Jul 15. Eur J Cell Biol. 2025. PMID: 40749357 Free PMC article.
Abstract
Gigaxonin is an intermediate filament (IF)-interacting partner belonging to the Kelch-like (KLHL) protein family. Gigaxonin is encoded by the KLHL16 gene, which is mutated in Giant Axonal Neuropathy (GAN). The lack of functional gigaxonin in GAN patient cells impairs IF proteostasis, leading to focal abnormal accumulations of IFs and compromised neuronal function. We hypothesized that gigaxonin forms molecular interactions via specific sequence motifs to regulate IF proteostasis. The goal of this study was to examine how distinct Kelch motifs on gigaxonin regulate IF protein degradation and filament morphology. We analyzed vimentin IFs in HEK293 cells overexpressing wild type (WT) gigaxonin, or gigaxonin lacking each of the six individual Kelch motifs: K1 (aa274-326), K2 (aa327-374), K3 (aa376-421), K4 (aa422-468), K5 (aa470-522), and K6 (aa528-574). All six gigaxonin deletion mutants (ΔK1-ΔK6) promoted the degradation of soluble vimentin. The ΔK3 gigaxonin mutant exhibited soluble vimentin degradation and promoted the bundling of vimentin IFs relative to WT gigaxonin. Using mass spectrometry proteomic analysis we found that, relative to WT gigaxonin, ΔK3 gigaxonin had increased associations with ubiquitination-associated and mitochondrial proteins and lost the association with the NudC domain-containing protein 3 (NUDCD3), a molecular chaperone enriched in the nervous system. Collectively, our cell biological data show the induction of an abnormal GAN-like IF phenotype in cells expressing ΔK3-gigaxonin, while our mass spectrometry profiling links the loss of gigaxonin-NUDCD3 interactions with defective IF proteostasis, revealing NUDCD3 as a potential new target in GAN.
Conflict of interest statement
Conflict of interest The authors declare there are no conflicts of interest.
Figures
References
-
- Bharucha-Goebel D.X., Norato G., Saade D., Paredes E., Biancavilla V., Donkervoort S., Kaur R., Lehky T., Fink M., Armao D., Gray S.J., Waite M., Debs S., Averion G., Hu Y., Zein W.M., Foley A.R., Jain M., Bonnemann C.G., 2021. Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort. Brain 144, 3239–3250. - PMC - PubMed
-
- Boizot A., Talmat-Amar Y., Morrogh D., Kuntz N.L., Halbert C., Chabrol B., Houlden H., Stojkovic T., Schulman B.A., Rautenstrauss B., Bomont P., 2014. The instability of the BTB-KELCH protein Gigaxonin causes Giant Axonal Neuropathy and constitutes a new penetrant and specific diagnostic test. Acta Neuropathol Commun 2, 47. - PMC - PubMed
-
- Bomont P., Cavalier L., Blondeau F., Ben Hamida C., Belal S., Tazir M., Demir E., Topaloglu H., Korinthenberg R., Tuysuz B., Landrieu P., Hentati F., Koenig M., 2000. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 26, 370–374. - PubMed
-
- Cai Y., Yang Y., Shen M., Zhou T., 2009. Inhibition of cytokinesis by overexpression of NudCL that is localized to the centrosome and midbody. Cell Res 19, 1305–1308. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous